Kinaxis Inc. (TSE:KXS – Get Free Report) insider Mark Justin Morgan sold 3,000 shares of Kinaxis stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of C$172.25, for a total value of C$516,750.00. Following the completion of the sale, the insider directly owned 10,299 shares of the company’s stock, valued at approximately C$1,774,002.75. This trade represents a 22.56% decrease in their position.
Kinaxis Stock Performance
Kinaxis stock traded down C$1.52 during midday trading on Wednesday, reaching C$169.22. The stock had a trading volume of 65,898 shares, compared to its average volume of 122,506. The firm has a market capitalization of C$4.60 billion, a PE ratio of 55.30, a P/E/G ratio of 3.60 and a beta of 0.76. Kinaxis Inc. has a 12 month low of C$117.22 and a 12 month high of C$201.00. The company has a quick ratio of 2.29, a current ratio of 1.88 and a debt-to-equity ratio of 11.14. The firm’s 50-day moving average price is C$158.22 and its 200 day moving average price is C$145.34.
Kinaxis (TSE:KXS – Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported C$1.08 earnings per share for the quarter. The firm had revenue of C$230.64 million during the quarter. Kinaxis had a net margin of 14.40% and a return on equity of 20.88%. As a group, research analysts predict that Kinaxis Inc. will post 4.2526231 earnings per share for the current fiscal year.
Analyst Ratings Changes
Get Our Latest Analysis on Kinaxis
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Featured Articles
- Five stocks we like better than Kinaxis
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
